vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $141.8M, roughly 1.5× BLACKBERRY Ltd). BLACKBERRY Ltd runs the higher net margin — 9.7% vs 2.7%, a 7.0% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -0.8%). BLACKBERRY Ltd produced more free cash flow last quarter ($17.4M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 17.8%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

BB vs IRTC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.5× larger
IRTC
$208.9M
$141.8M
BB
Growing faster (revenue YoY)
IRTC
IRTC
+28.0% gap
IRTC
27.1%
-0.8%
BB
Higher net margin
BB
BB
7.0% more per $
BB
9.7%
2.7%
IRTC
More free cash flow
BB
BB
$2.9M more FCF
BB
$17.4M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
17.8%
BB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
IRTC
IRTC
Revenue
$141.8M
$208.9M
Net Profit
$13.7M
$5.6M
Gross Margin
77.5%
70.9%
Operating Margin
8.4%
1.1%
Net Margin
9.7%
2.7%
Revenue YoY
-0.8%
27.1%
Net Profit YoY
224.5%
518.5%
EPS (diluted)
$0.02
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
IRTC
IRTC
Q4 25
$141.8M
$208.9M
Q3 25
$129.6M
$192.9M
Q2 25
$121.7M
$186.7M
Q1 25
$141.7M
$158.7M
Q4 24
$143.6M
$164.3M
Q3 24
$126.2M
$147.5M
Q2 24
$123.4M
$148.0M
Q1 24
$102.1M
$131.9M
Net Profit
BB
BB
IRTC
IRTC
Q4 25
$13.7M
$5.6M
Q3 25
$13.3M
$-5.2M
Q2 25
$1.9M
$-14.2M
Q1 25
$-7.4M
$-30.7M
Q4 24
$-10.5M
$-1.3M
Q3 24
$-19.7M
$-46.2M
Q2 24
$-41.4M
$-20.1M
Q1 24
$-56.2M
$-45.7M
Gross Margin
BB
BB
IRTC
IRTC
Q4 25
77.5%
70.9%
Q3 25
74.5%
71.1%
Q2 25
74.2%
71.2%
Q1 25
73.5%
68.8%
Q4 24
78.1%
70.0%
Q3 24
70.2%
68.8%
Q2 24
72.9%
69.9%
Q1 24
66.3%
Operating Margin
BB
BB
IRTC
IRTC
Q4 25
8.4%
1.1%
Q3 25
8.9%
-4.4%
Q2 25
1.6%
-10.0%
Q1 25
-5.6%
-20.5%
Q4 24
13.6%
-2.5%
Q3 24
1.7%
-34.1%
Q2 24
-10.5%
-15.5%
Q1 24
50.0%
-28.9%
Net Margin
BB
BB
IRTC
IRTC
Q4 25
9.7%
2.7%
Q3 25
10.3%
-2.7%
Q2 25
1.6%
-7.6%
Q1 25
-5.2%
-19.3%
Q4 24
-7.3%
-0.8%
Q3 24
-15.6%
-31.3%
Q2 24
-33.5%
-13.6%
Q1 24
-55.0%
-34.6%
EPS (diluted)
BB
BB
IRTC
IRTC
Q4 25
$0.02
$0.18
Q3 25
$0.02
$-0.16
Q2 25
$0.00
$-0.44
Q1 25
$-0.01
$-0.97
Q4 24
$-0.02
$-0.03
Q3 24
$-0.03
$-1.48
Q2 24
$-0.07
$-0.65
Q1 24
$-0.08
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$304.2M
$583.8M
Total DebtLower is stronger
$196.2M
Stockholders' EquityBook value
$741.1M
$152.7M
Total Assets
$1.2B
$1.0B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
IRTC
IRTC
Q4 25
$304.2M
$583.8M
Q3 25
$290.5M
$565.2M
Q2 25
$306.6M
$545.5M
Q1 25
$337.8M
$520.6M
Q4 24
$220.0M
$535.6M
Q3 24
$211.0M
$522.0M
Q2 24
$229.0M
$561.5M
Q1 24
$237.1M
$569.1M
Total Debt
BB
BB
IRTC
IRTC
Q4 25
$196.2M
Q3 25
$195.9M
Q2 25
$195.6M
Q1 25
$195.3M
Q4 24
Q3 24
Q2 24
Q1 24
$194.1M
Stockholders' Equity
BB
BB
IRTC
IRTC
Q4 25
$741.1M
$152.7M
Q3 25
$725.1M
$121.9M
Q2 25
$725.1M
$103.7M
Q1 25
$719.9M
$86.7M
Q4 24
$725.2M
$90.9M
Q3 24
$732.1M
$71.8M
Q2 24
$742.6M
$99.2M
Q1 24
$775.1M
$90.3M
Total Assets
BB
BB
IRTC
IRTC
Q4 25
$1.2B
$1.0B
Q3 25
$1.2B
$995.2M
Q2 25
$1.2B
$964.0M
Q1 25
$1.3B
$926.1M
Q4 24
$1.3B
$931.4M
Q3 24
$1.3B
$909.7M
Q2 24
$1.3B
$919.2M
Q1 24
$1.4B
$909.8M
Debt / Equity
BB
BB
IRTC
IRTC
Q4 25
0.26×
Q3 25
0.27×
Q2 25
0.27×
Q1 25
0.27×
Q4 24
Q3 24
Q2 24
Q1 24
0.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
IRTC
IRTC
Operating Cash FlowLast quarter
$18.3M
$26.2M
Free Cash FlowOCF − Capex
$17.4M
$14.5M
FCF MarginFCF / Revenue
12.3%
6.9%
Capex IntensityCapex / Revenue
0.6%
5.6%
Cash ConversionOCF / Net Profit
1.34×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$42.8M
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
IRTC
IRTC
Q4 25
$18.3M
$26.2M
Q3 25
$3.9M
$34.9M
Q2 25
$-18.0M
$27.7M
Q1 25
$41.6M
$-7.9M
Q4 24
$6.0M
$19.2M
Q3 24
$-16.0M
$24.3M
Q2 24
$-15.1M
$11.8M
Q1 24
$-15.5M
$-52.0M
Free Cash Flow
BB
BB
IRTC
IRTC
Q4 25
$17.4M
$14.5M
Q3 25
$3.1M
$20.1M
Q2 25
$-18.9M
$17.3M
Q1 25
$41.2M
$-17.3M
Q4 24
$5.2M
$12.4M
Q3 24
$-16.5M
$15.5M
Q2 24
$-16.5M
$3.4M
Q1 24
$-17.6M
$-61.8M
FCF Margin
BB
BB
IRTC
IRTC
Q4 25
12.3%
6.9%
Q3 25
2.4%
10.4%
Q2 25
-15.5%
9.3%
Q1 25
29.1%
-10.9%
Q4 24
3.6%
7.5%
Q3 24
-13.1%
10.5%
Q2 24
-13.4%
2.3%
Q1 24
-17.2%
-46.8%
Capex Intensity
BB
BB
IRTC
IRTC
Q4 25
0.6%
5.6%
Q3 25
0.6%
7.7%
Q2 25
0.7%
5.6%
Q1 25
0.3%
5.9%
Q4 24
0.6%
4.2%
Q3 24
0.4%
6.0%
Q2 24
1.1%
5.7%
Q1 24
2.1%
7.4%
Cash Conversion
BB
BB
IRTC
IRTC
Q4 25
1.34×
4.70×
Q3 25
0.29×
Q2 25
-9.47×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons